Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Fibroma × Sarcoma × Clear all

Phase

Status

Unknown 2 Withdrawn 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 44 Gliosarcoma 16 Glioblastoma 16 Osteosarcoma 11 Lymphoma 11 Central Nervous System Neoplasms 11 Neuroblastoma 10 Dendritic Cell Sarcoma, Interdigitating 10 Oligodendroglioma 9 Brain Neoplasms 9 Bone Neoplasms 9 Astrocytoma 9 Rhabdomyosarcoma 8 Lymphoma, Large B-Cell, Diffuse 8 Breast Neoplasms 8 Recurrence 7 Neoplasms 7 Glioma 7 Gastrointestinal Stromal Tumors 7 Wilms Tumor 6 Sarcoma, Ewing 6 Neoplasm Metastasis 6 Medulloblastoma 6 Lymphoma, Non-Hodgkin 6 Liposarcoma 6 Burkitt Lymphoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Hodgkin Disease 5 Hemangiosarcoma 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡